In This Article:
Urges Shareholders to Vote AGAINST Both Proposals Related to the Value-Destructive Merger with Akoya at the Upcoming Special Meeting
Notes Deeply Unfair Merger is Effectively a Bailout for Akoya at the Expense of Quanterix Shareholders
Outlines Concerns Around Fundamentally Flawed Transaction Process and Conflicts of Interest Among Quanterix Board Members
Visit www.SaveQTRX.com to Learn How to Vote the GOLD Proxy Card and Preserve Quanterix’s Clear and Compelling Path Toward Long-Term Value Creation
RINCON, Puerto Rico, April 17, 2025--(BUSINESS WIRE)--Kent Lake PR LLC ("Kent Lake"), a holder of approximately 7.7% of the outstanding common stock of Quanterix Corporation ("Quanterix" or the "Company") (NASDAQ: QTRX), today announced that it has filed a definitive proxy statement with the U.S. Securities and Exchange Commission (the "SEC") and sent a letter to its fellow Quanterix shareholders in connection with its opposition to the Company’s proposed merger (the "Merger") with Akoya Biosciences ("Akoya") (NASDAQ: AKYA).
The full text of Kent Lake’s letter can be found here: https://bit.ly/4ly8pZl
Kent Lake urges shareholders to vote AGAINST both proposals related to the value-destructive Merger with Akoya on the GOLD proxy card at the upcoming special meeting of shareholders (the "Special Meeting") scheduled for May 13, 2025.
For more information on how to vote and other relevant resources, shareholders are encouraged to visit www.SaveQTRX.com.
If you have any questions, require assistance in voting your GOLD proxy card, or need additional copies of Kent Lake’s proxy materials, please contact:
Saratoga Proxy Consulting LLC
520 8th Avenue
New York, NY 10018
Stockholders call toll-free at (888) 368-0379
Email: info@saratogaproxy.com
About Kent Lake
Kent Lake Partners LP is an investment fund founded by Ben Natter in 2019 with a focus on small and mid-capitalization public equities, particularly in the healthcare space. Mr. Natter has over a decade of successful public healthcare equity investing experience.
Certain Information Concerning the Participants
Kent Lake Partners LP ("Kent Lake Partners") has filed a definitive proxy statement and accompanying GOLD proxy card with the Securities and Exchange Commission ("SEC") to be used to solicit votes in connection with its opposition to proposals to be presented at a special meeting of stockholders (the "Special Meeting") of Quanterix Corporation, a Delaware corporation (the "Company"), in connection with the Company’s agreement and plan of merger (the "Merger") with Akoya Biosciences, Inc. Kent Lake Partners, together with the other Participants (as defined below), also intends to file a preliminary proxy statement and accompanying GOLD universal proxy card with the SEC to be used to solicit votes for, among other matters, the election of its slate of highly-qualified director nominees at the 2025 annual meeting of stockholders of the Company (the "Annual Meeting").